|Day's Range||74.42 - 74.81|
|52 Week Range||61.05 - 74.92|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.40%|
This article is part of a regular series of thought leadership pieces from some of the more influential ETF strategists in the money management industry. Today's article is by Scott Kubie, chief strategist of Omaha, Nebraska-based CLS Investments. International value stocks look cheap. The iShares MSCI EAFE Value (EFV) is attractive compared with other diversified, developed international indexes and ETFs.
Roche (RHHBY) noted that Tecentriq was granted Breakthrough therapy designation for use in the treatment of NSCLC.
Got a case of TMI (Too Much Information)? ETF Trends takes a condensed look at latest happenings… The Day’s Hot News In Equity ETFs Markets saw what appeared to be a rotation in U.S. equities and fixed ...